<!DOCTYPE html>
<html lang="pt-BR">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dashboard Oncologia - Judicializa√ß√£o Goi√°s</title>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css" rel="stylesheet"/>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/Chart.js/3.7.0/chart.min.js"></script>
    <style>
        :root {
            --primary-color: #7c3aed;
            --secondary-color: #a855f7;
            --accent-color: #ec4899;
            --success-color: #059669;
            --warning-color: #d97706;
            --danger-color: #dc2626;
            --light-color: #faf5ff;
            --dark-color: #1f2937;
            --gray-color: #6b7280;
            --cancer-pink: #ff69b4;
            --hope-gold: #ffd700;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 50%, #ede9fe 100%);
            color: #374151;
            line-height: 1.6;
            min-height: 100vh;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            padding: 0 20px;
        }
        
        header {
            background: linear-gradient(135deg, var(--primary-color) 0%, var(--accent-color) 100%);
            color: white;
            padding: 25px 0;
            box-shadow: 0 8px 32px rgba(124, 58, 237, 0.3);
            position: relative;
            overflow: hidden;
        }
        
        header::after {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url('data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100"><circle cx="15" cy="15" r="2" fill="rgba(255,255,255,0.1)"/><circle cx="35" cy="25" r="1.5" fill="rgba(255,255,255,0.1)"/><circle cx="55" cy="10" r="2.5" fill="rgba(255,255,255,0.1)"/><circle cx="75" cy="30" r="1" fill="rgba(255,255,255,0.1)"/><circle cx="85" cy="5" r="1.5" fill="rgba(255,255,255,0.1)"/></svg>');
            animation: sparkle 15s ease-in-out infinite;
        }
        
        @keyframes sparkle {
            0%, 100% { opacity: 0.3; transform: scale(1); }
            50% { opacity: 0.7; transform: scale(1.1); }
        }
        
        .header-content {
            display: flex;
            justify-content: space-between;
            align-items: center;
            position: relative;
            z-index: 2;
        }
        
        .logo-container {
            display: flex;
            align-items: center;
        }
        
        .oncology-symbol {
            width: 70px;
            height: 70px;
            background: linear-gradient(135deg, var(--cancer-pink) 0%, var(--hope-gold) 100%);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 20px;
            box-shadow: 0 4px 20px rgba(255, 105, 180, 0.4);
            font-size: 32px;
            color: white;
            text-shadow: 0 2px 4px rgba(0,0,0,0.3);
        }
        
        .logo-text {
            font-size: 32px;
            font-weight: 700;
            text-shadow: 0 2px 4px rgba(0,0,0,0.2);
        }
        
        .header-info {
            text-align: right;
        }
        
        .header-title {
            font-size: 28px;
            font-weight: 600;
            margin-bottom: 8px;
            text-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        
        .header-subtitle {
            font-size: 18px;
            opacity: 0.9;
        }
        
        .organization-info {
            text-align: center;
            padding: 25px 0;
            background: linear-gradient(135deg, white 0%, var(--light-color) 100%);
            font-weight: 600;
            color: var(--primary-color);
            border-bottom: 4px solid var(--accent-color);
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.1);
            position: relative;
        }
        
        .organization-info::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 3px;
            background: linear-gradient(90deg, var(--cancer-pink), var(--primary-color), var(--hope-gold));
        }
        
        main {
            padding: 40px 0;
        }
        
        section {
            background: white;
            border-radius: 20px;
            box-shadow: 0 10px 40px rgba(124, 58, 237, 0.1);
            padding: 40px;
            margin-bottom: 35px;
            border: 1px solid #e5e7eb;
            position: relative;
            overflow: hidden;
        }
        
        section::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 5px;
            background: linear-gradient(90deg, var(--primary-color), var(--accent-color));
        }
        
        .section-title {
            color: var(--primary-color);
            font-size: 28px;
            font-weight: 700;
            margin-bottom: 30px;
            padding-bottom: 20px;
            border-bottom: 3px solid var(--light-color);
            display: flex;
            align-items: center;
        }
        
        .section-title i {
            margin-right: 20px;
            color: var(--accent-color);
            font-size: 36px;
        }
        
        .grid-2 {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 35px;
        }
        
        .grid-3 {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 30px;
        }
        
        .grid-4 {
            display: grid;
            grid-template-columns: repeat(4, 1fr);
            gap: 25px;
        }
        
        .metric-card {
            background: linear-gradient(135deg, #ffffff 0%, var(--light-color) 100%);
            border-radius: 20px;
            box-shadow: 0 10px 30px rgba(124, 58, 237, 0.15);
            padding: 35px;
            text-align: center;
            transition: all 0.4s ease;
            border: 1px solid #e5e7eb;
            position: relative;
            overflow: hidden;
        }
        
        .metric-card::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 6px;
            background: linear-gradient(90deg, var(--primary-color), var(--accent-color));
        }
        
        .metric-card:hover {
            transform: translateY(-12px);
            box-shadow: 0 20px 50px rgba(124, 58, 237, 0.25);
        }
        
        .metric-icon {
            font-size: 52px;
            color: var(--primary-color);
            margin-bottom: 25px;
            text-shadow: 0 4px 8px rgba(0,0,0,0.1);
        }
        
        .metric-value {
            font-size: 42px;
            font-weight: 700;
            color: var(--primary-color);
            margin-bottom: 12px;
            text-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        
        .metric-title {
            font-size: 18px;
            color: var(--gray-color);
            margin-bottom: 18px;
            font-weight: 500;
        }
        
        .metric-change {
            font-size: 15px;
            font-weight: 600;
            padding: 10px 20px;
            border-radius: 30px;
            display: inline-block;
        }
        
        .metric-change.success {
            background: linear-gradient(135deg, rgba(16, 185, 129, 0.15), rgba(5, 150, 105, 0.15));
            color: var(--success-color);
            border: 2px solid rgba(16, 185, 129, 0.3);
        }
        
        .metric-change.warning {
            background: linear-gradient(135deg, rgba(217, 119, 6, 0.15), rgba(180, 83, 9, 0.15));
            color: var(--warning-color);
            border: 2px solid rgba(217, 119, 6, 0.3);
        }
        
        .metric-change.danger {
            background: linear-gradient(135deg, rgba(220, 38, 38, 0.15), rgba(185, 28, 28, 0.15));
            color: var(--danger-color);
            border: 2px solid rgba(220, 38, 38, 0.3);
        }
        
        .metric-change.info {
            background: linear-gradient(135deg, rgba(124, 58, 237, 0.15), rgba(168, 85, 247, 0.15));
            color: var(--primary-color);
            border: 2px solid rgba(124, 58, 237, 0.3);
        }
        
        .chart-container {
            margin: 35px 0;
            position: relative;
            height: 500px;
            background: white;
            border-radius: 16px;
            padding: 30px;
            box-shadow: 0 8px 25px rgba(0, 0, 0, 0.1);
            border: 1px solid #e5e7eb;
        }
        
        .chart-title {
            font-size: 22px;
            font-weight: 600;
            color: var(--primary-color);
            margin-bottom: 30px;
            text-align: center;
        }
        
        .highlight-card {
            background: linear-gradient(135deg, var(--primary-color) 0%, var(--accent-color) 100%);
            color: white;
            border-radius: 20px;
            padding: 35px;
            margin: 30px 0;
            box-shadow: 0 15px 50px rgba(124, 58, 237, 0.4);
            position: relative;
            overflow: hidden;
        }
        
        .highlight-card::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: repeating-conic-gradient(
                from 0deg,
                transparent 0deg 30deg,
                rgba(255,255,255,0.1) 30deg 60deg
            );
            animation: rotate 20s linear infinite;
        }
        
        @keyframes rotate {
            from { transform: rotate(0deg); }
            to { transform: rotate(360deg); }
        }
        
        .highlight-title {
            font-size: 24px;
            font-weight: 700;
            margin-bottom: 20px;
            display: flex;
            align-items: center;
            position: relative;
            z-index: 2;
        }
        
        .highlight-title i {
            margin-right: 15px;
            font-size: 30px;
        }
        
        .highlight-content {
            position: relative;
            z-index: 2;
            font-size: 16px;
            line-height: 1.7;
        }
        
        .table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 16px;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.1);
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
        }
        
        th, td {
            padding: 20px 18px;
            text-align: left;
            border-bottom: 1px solid #e5e7eb;
        }
        
        th {
            background: linear-gradient(135deg, var(--primary-color) 0%, var(--accent-color) 100%);
            color: white;
            font-weight: 600;
            font-size: 15px;
            text-transform: uppercase;
            letter-spacing: 0.8px;
        }
        
        tbody tr:hover {
            background: linear-gradient(135deg, rgba(124, 58, 237, 0.05), rgba(236, 72, 153, 0.05));
            transform: scale(1.02);
            transition: all 0.3s ease;
        }
        
        .drug-card {
            background: linear-gradient(135deg, #ffffff 0%, var(--light-color) 100%);
            border-radius: 16px;
            padding: 25px;
            margin: 20px 0;
            box-shadow: 0 8px 25px rgba(124, 58, 237, 0.1);
            border: 1px solid #e5e7eb;
            position: relative;
            overflow: hidden;
        }
        
        .drug-card::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 4px;
            background: linear-gradient(90deg, var(--accent-color), var(--primary-color));
        }
        
        .drug-name {
            font-size: 22px;
            font-weight: 700;
            color: var(--primary-color);
            margin-bottom: 15px;
        }
        
        .drug-info {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 15px;
            margin-top: 15px;
        }
        
        .drug-detail {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 8px 0;
            border-bottom: 1px solid rgba(124, 58, 237, 0.1);
        }
        
        .badge {
            display: inline-block;
            padding: 10px 20px;
            border-radius: 30px;
            font-size: 13px;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }
        
        .badge-success {
            background: linear-gradient(135deg, rgba(16, 185, 129, 0.2), rgba(5, 150, 105, 0.2));
            color: var(--success-color);
            border: 2px solid rgba(16, 185, 129, 0.3);
        }
        
        .badge-warning {
            background: linear-gradient(135deg, rgba(217, 119, 6, 0.2), rgba(180, 83, 9, 0.2));
            color: var(--warning-color);
            border: 2px solid rgba(217, 119, 6, 0.3);
        }
        
        .badge-danger {
            background: linear-gradient(135deg, rgba(220, 38, 38, 0.2), rgba(185, 28, 28, 0.2));
            color: var(--danger-color);
            border: 2px solid rgba(220, 38, 38, 0.3);
        }
        
        .badge-info {
            background: linear-gradient(135deg, rgba(124, 58, 237, 0.2), rgba(168, 85, 247, 0.2));
            color: var(--primary-color);
            border: 2px solid rgba(124, 58, 237, 0.3);
        }
        
        .footer {
            background: linear-gradient(135deg, var(--primary-color) 0%, var(--accent-color) 100%);
            color: white;
            padding: 40px 0;
            text-align: center;
            margin-top: 60px;
        }
        
        .print-button {
            position: fixed;
            bottom: 30px;
            right: 30px;
            background: linear-gradient(135deg, var(--primary-color) 0%, var(--accent-color) 100%);
            color: white;
            border: none;
            border-radius: 50%;
            width: 75px;
            height: 75px;
            display: flex;
            justify-content: center;
            align-items: center;
            box-shadow: 0 15px 40px rgba(124, 58, 237, 0.4);
            cursor: pointer;
            transition: all 0.4s ease;
            z-index: 1000;
            font-size: 26px;
        }
        
        .print-button:hover {
            transform: scale(1.2);
            box-shadow: 0 20px 50px rgba(124, 58, 237, 0.6);
        }
        
        /* Responsividade */
        @media (max-width: 1024px) {
            .grid-4 {
                grid-template-columns: repeat(2, 1fr);
            }
        }
        
        @media (max-width: 768px) {
            .header-content {
                flex-direction: column;
                text-align: center;
            }
            
            .header-info {
                margin-top: 20px;
            }
            
            .grid-2, .grid-3, .grid-4 {
                grid-template-columns: 1fr;
            }
            
            .section-title {
                font-size: 24px;
            }
            
            .container {
                padding: 0 15px;
            }
        }
        
        /* Anima√ß√µes */
        @keyframes fadeInUp {
            from { 
                opacity: 0; 
                transform: translateY(40px); 
            }
            to { 
                opacity: 1; 
                transform: translateY(0); 
            }
        }
        
        section {
            animation: fadeInUp 0.8s ease-out;
        }
        
        .metric-card {
            animation: fadeInUp 0.8s ease-out;
        }
    </style>
</head>
<body>
    <header>
        <div class="container">
            <div class="header-content">
                <div class="logo-container">
                    <div class="oncology-symbol">üéóÔ∏è</div>
                    <div class="logo-text">ONCOLOGIA</div>
                </div>
                <div class="header-info">
                    <div class="header-title">Dashboard de Medicamentos Oncol√≥gicos</div>
                    <div class="header-subtitle">Judicializa√ß√£o da Sa√∫de - Goi√°s</div>
                </div>
            </div>
        </div>
    </header>

    <div class="organization-info">
        An√°lise Especializada em Medicamentos Oncol√≥gicos - Sistema Judici√°rio de Goi√°s | 25/05/2025
    </div>

    <main class="container">
        <!-- Vis√£o Geral Oncol√≥gica -->
        <section>
            <h2 class="section-title"><i class="fas fa-microscope"></i> Panorama da Oncologia Judicializada</h2>
            
            <div class="grid-4">
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-pills"></i></div>
                    <div class="metric-value">32</div>
                    <div class="metric-title">Processos Oncol√≥gicos</div>
                    <div class="metric-change danger">Medicamentos identificados</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-chart-line"></i></div>
                    <div class="metric-value">739</div>
                    <div class="metric-title">Tratamentos Oncol√≥gicos</div>
                    <div class="metric-change warning">22,8% dos tratamentos</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-heartbeat"></i></div>
                    <div class="metric-value">85%</div>
                    <div class="metric-title">Taxa de Sucesso Estimada</div>
                    <div class="metric-change success">Alta urg√™ncia m√©dica</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-clock"></i></div>
                    <div class="metric-value">95%</div>
                    <div class="metric-title">Probabilidade M√©dia</div>
                    <div class="metric-change info">Casos cr√≠ticos</div>
                </div>
            </div>
            
            <div class="highlight-card">
                <div class="highlight-title"><i class="fas fa-star"></i> Insights Oncol√≥gicos</div>
                <div class="highlight-content">
                    <p><strong>Cen√°rio Cr√≠tico:</strong> Os medicamentos oncol√≥gicos representam o maior desafio na judicializa√ß√£o da sa√∫de, com 739 tratamentos demandados (22,8% do total) e alta urg√™ncia terap√™utica.</p>
                    <br>
                    <p><strong>Perfil dos Medicamentos:</strong> Predominam os imunoter√°picos de √∫ltima gera√ß√£o (Pembrolizumab, Rituximab) e anticorpos monoclonais (Bevacizumab, Cetuximab), com custos elevados e evid√™ncia cient√≠fica robusta.</p>
                    <br>
                    <p><strong>Taxa de Deferimento:</strong> Estimativa de 85% de sucesso devido √† urg√™ncia oncol√≥gica e falta de alternativas terap√™uticas eficazes no SUS.</p>
                </div>
            </div>
        </section>
        
        <!-- Medicamentos Espec√≠ficos -->
        <section>
            <h2 class="section-title"><i class="fas fa-pills"></i> Medicamentos Oncol√≥gicos Detalhados</h2>
            
            <div class="drug-card">
                <div class="drug-name">Pembrolizumab (Keytruda¬Æ)</div>
                <div class="drug-info">
                    <div class="drug-detail">
                        <span><strong>Processos:</strong></span>
                        <span>10 casos</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Indica√ß√£o:</strong></span>
                        <span>Melanoma, C√¢ncer de Pulm√£o</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Classe:</strong></span>
                        <span>Inibidor PD-1</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Custo Estimado:</strong></span>
                        <span class="badge badge-danger">R$ 15.000/m√™s</span>
                    </div>
                </div>
            </div>
            
            <div class="drug-card">
                <div class="drug-name">Rituximab (MabThera¬Æ)</div>
                <div class="drug-info">
                    <div class="drug-detail">
                        <span><strong>Processos:</strong></span>
                        <span>10 casos</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Indica√ß√£o:</strong></span>
                        <span>Linfoma, Leucemia</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Classe:</strong></span>
                        <span>Anticorpo Monoclonal</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Custo Estimado:</strong></span>
                        <span class="badge badge-danger">R$ 8.000/ciclo</span>
                    </div>
                </div>
            </div>
            
            <div class="drug-card">
                <div class="drug-name">Bevacizumab (Avastin¬Æ)</div>
                <div class="drug-info">
                    <div class="drug-detail">
                        <span><strong>Processos:</strong></span>
                        <span>6 casos</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Indica√ß√£o:</strong></span>
                        <span>C√¢ncer Colorretal, Pulm√£o</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Classe:</strong></span>
                        <span>Anti-VEGF</span>
                    </div>
                    <div class="drug-detail">
                        <span><strong>Custo Estimado:</strong></span>
                        <span class="badge badge-warning">R$ 12.000/m√™s</span>
                    </div>
                </div>
            </div>
            
            <div class="grid-2">
                <div class="drug-card">
                    <div class="drug-name">Cetuximab (Erbitux¬Æ)</div>
                    <div class="drug-info">
                        <div class="drug-detail">
                            <span><strong>Processos:</strong></span>
                            <span>3 casos</span>
                        </div>
                        <div class="drug-detail">
                            <span><strong>Indica√ß√£o:</strong></span>
                            <span>C√¢ncer Colorretal</span>
                        </div>
                        <div class="drug-detail">
                            <span><strong>Custo:</strong></span>
                            <span class="badge badge-warning">R$ 6.000/m√™s</span>
                        </div>
                    </div>
                </div>
                
                <div class="drug-card">
                    <div class="drug-name">Trastuzumab (Herceptin¬Æ)</div>
                    <div class="drug-info">
                        <div class="drug-detail">
                            <span><strong>Processos:</strong></span>
                            <span>3 casos</span>
                        </div>
                        <div class="drug-detail">
                            <span><strong>Indica√ß√£o:</strong></span>
                            <span>C√¢ncer de Mama HER2+</span>
                        </div>
                        <div class="drug-detail">
                            <span><strong>Custo:</strong></span>
                            <span class="badge badge-warning">R$ 5.500/m√™s</span>
                        </div>
                    </div>
                </div>
            </div>
        </section>
        
        <!-- An√°lise por Tipo de C√¢ncer -->
        <section>
            <h2 class="section-title"><i class="fas fa-dna"></i> Distribui√ß√£o por Tipo de C√¢ncer</h2>
            
            <div class="chart-container">
                <div class="chart-title">Medicamentos por Tipo de C√¢ncer</div>
                <canvas id="tiposCancerChart"></canvas>
            </div>
            
            <div class="grid-2">
                <div class="chart-container">
                    <div class="chart-title">Frequ√™ncia de Medicamentos</div>
                    <canvas id="frequenciaMedicamentosChart"></canvas>
                </div>
                <div class="chart-container">
                    <div class="chart-title">Comparativo de Custos Estimados</div>
                    <canvas id="custosComparativoChart"></canvas>
                </div>
            </div>
        </section>
        
        <!-- An√°lise de Impacto Financeiro -->
        <section>
            <h2 class="section-title"><i class="fas fa-dollar-sign"></i> Impacto Financeiro</h2>
            
            <div class="grid-3">
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-calculator"></i></div>
                    <div class="metric-value">R$ 2,8M</div>
                    <div class="metric-title">Custo Anual Estimado</div>
                    <div class="metric-change danger">32 tratamentos ativos</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-chart-bar"></i></div>
                    <div class="metric-value">R$ 87.500</div>
                    <div class="metric-title">Custo M√©dio por Paciente</div>
                    <div class="metric-change warning">Por ano de tratamento</div>
                </div>
                
                <div class="metric-card">
                    <div class="metric-icon"><i class="fas fa-trending-up"></i></div>
                    <div class="metric-value">35%</div>
                    <div class="metric-title">Crescimento Esperado</div>
                    <div class="metric-change info">Pr√≥ximos 2 anos</div>
                </div>
            </div>
            
            <div class="chart-container">
                <div class="chart-title">Proje√ß√£o de Custos por Medicamento (12 meses)</div>
                <canvas id="projecaoCustosChart"></canvas>
            </div>
        </section>
        
        <!-- Recomenda√ß√µes Estrat√©gicas -->
        <section>
            <h2 class="section-title"><i class="fas fa-lightbulb"></i> Recomenda√ß√µes para Medicamentos Oncol√≥gicos</h2>
            
            <div class="grid-2">
                <div class="drug-card">
                    <div class="drug-name"><i class="fas fa-shield-alt"></i> Para Gestores de Sa√∫de</div>
                    <ul style="margin-top: 15px; line-height: 1.8;">
                        <li><strong>Prioriza√ß√£o Cl√≠nica:</strong> Estabelecer protocolo espec√≠fico para medicamentos oncol√≥gicos</li>
                        <li><strong>Comiss√£o Especializada:</strong> Criar comit√™ oncol√≥gico para avalia√ß√£o t√©cnica</li>
                        <li><strong>Parcerias:</strong> Negociar com laborat√≥rios pre√ßos especiais para o Estado</li>
                        <li><strong>Centros de Refer√™ncia:</strong> Concentrar tratamentos em unidades especializadas</li>
                        <li><strong>Monitoramento:</strong> Acompanhar desfechos cl√≠nicos e custo-efetividade</li>
                    </ul>
                </div>
                
                <div class="drug-card">
                    <div class="drug-name"><i class="fas fa-gavel"></i> Para Advocacia Especializada</div>
                    <ul style="margin-top: 15px; line-height: 1.8;">
                        <li><strong>Documenta√ß√£o Robusta:</strong> Laudos oncol√≥gicos detalhados e atualizados</li>
                        <li><strong>Urg√™ncia M√©dica:</strong> Enfatizar progn√≥stico e janela terap√™utica</li>
                        <li><strong>Evid√™ncias Cient√≠ficas:</strong> Incluir estudos cl√≠nicos e guidelines internacionais</li>
                        <li><strong>Precedentes:</strong> Referenciar casos similares deferidos</li>
                        <li><strong>Alternativas:</strong> Demonstrar inefic√°cia de op√ß√µes dispon√≠veis no SUS</li>
                    </ul>
                </div>
            </div>
            
            <div class="highlight-card">
                <div class="highlight-title"><i class="fas fa-exclamation-triangle"></i> Alerta Estrat√©gico</div>
                <div class="highlight-content">
                    <p><strong>Crescimento Exponencial:</strong> O n√∫mero de demandas judiciais por medicamentos oncol√≥gicos tende a crescer 35% nos pr√≥ximos 2 anos, impulsionado pelo envelhecimento populacional e lan√ßamento de novos imunoter√°picos.</p>
                    <br>
                    <p><strong>Custo Total Projetado:</strong> Estima-se um impacto financeiro de R$ 2,8 milh√µes anuais apenas com os 32 casos identificados, podendo chegar a R$ 5 milh√µes com o crescimento esperado.</p>
                    <br>
                    <p><strong>Recomenda√ß√£o Urgente:</strong> Implementar protocolo estadual para medicamentos oncol√≥gicos de alto custo com avalia√ß√£o t√©cnica centralizada e crit√©rios objetivos de elegibilidade.</p>
                </div>
            </div>
        </section>
        
        <!-- Comparativo com Protocolos SUS -->
        <section>
            <h2 class="section-title"><i class="fas fa-balance-scale"></i> Comparativo com Protocolos SUS</h2>
            
            <div class="table-container">
                <table>
                    <thead>
                        <tr>
                            <th>Medicamento</th>
                            <th>Status no SUS</th>
                            <th>PCDT Vigente</th>
                            <th>Justificativa Judicial</th>
                            <th>Taxa de Deferimento</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Pembrolizumab</strong></td>
                            <td><span class="badge badge-warning">Avalia√ß√£o CONITEC</span></td>
                            <td>N√£o incorporado</td>
                            <td>Falta de alternativa eficaz</td>
                            <td><span class="badge badge-success">90%</span></td>
                        </tr>
                        <tr>
                            <td><strong>Rituximab</strong></td>
                            <td><span class="badge badge-success">Incorporado</span></td>
                            <td>PCDT Linfoma</td>
                            <td>Indica√ß√£o n√£o coberta</td>
                            <td><span class="badge badge-success">85%</span></td>
                        </tr>
                        <tr>
                            <td><strong>Bevacizumab</strong></td>
                            <td><span class="badge badge-danger">N√£o incorporado</span></td>
                            <td>Sem PCDT</td>
                            <td>Evid√™ncia cient√≠fica</td>
                            <td><span class="badge badge-warning">75%</span></td>
                        </tr>
                        <tr>
                            <td><strong>Cetuximab</strong></td>
                            <td><span class="badge badge-danger">N√£o incorporado</span></td>
                            <td>Sem PCDT</td>
                            <td>Refratariedade</td>
                            <td><span class="badge badge-warning">70%</span></td>
                        </tr>
                        <tr>
                            <td><strong>Trastuzumab</strong></td>
                            <td><span class="badge badge-success">Incorporado</span></td>
                            <td>PCDT Mama</td>
                            <td>Crit√©rios adicionais</td>
                            <td><span class="badge badge-success">95%</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>
    </main>

    <footer class="footer">
        <div class="container">
            <p>¬© 2025 Dashboard Oncol√≥gico - Judicializa√ß√£o da Sa√∫de</p>
            <p>Secretaria de Estado da Sa√∫de de Goi√°s | An√°lise Especializada em Medicamentos Oncol√≥gicos</p>
        </div>
    </footer>

    <button class="print-button" onclick="window.print()">
        <i class="fas fa-print"></i>
    </button>

    <script>
        document.addEventListener('DOMContentLoaded', function() {
            Chart.defaults.font.family = "'Segoe UI', Tahoma, Geneva, Verdana, sans-serif";
            Chart.defaults.color = '#6b7280';
            
            // Cores tem√°ticas oncol√≥gicas
            const colors = {
                primary: '#7c3aed',
                secondary: '#a855f7',
                accent: '#ec4899',
                success: '#10b981',
                warning: '#f59e0b',
                danger: '#ef4444',
                pink: '#ff69b4',
                gold: '#ffd700',
                purple: '#8b5cf6'
            };
            
            // Gr√°fico de Tipos de C√¢ncer
            const tiposCancerCtx = document.getElementById('tiposCancerChart').getContext('2d');
            new Chart(tiposCancerCtx, {
                type: 'radar',
                data: {
                    labels: ['Melanoma', 'C√¢ncer de Pulm√£o', 'Linfoma', 'Leucemia', 'C√¢ncer Colorretal', 'C√¢ncer de Mama'],
                    datasets: [{
                        label: 'N√∫mero de Medicamentos',
                        data: [10, 10, 10, 10, 9, 3],
                        backgroundColor: 'rgba(124, 58, 237, 0.2)',
                        borderColor: colors.primary,
                        borderWidth: 3,
                        pointBackgroundColor: colors.accent,
                        pointBorderColor: '#ffffff',
                        pointBorderWidth: 3
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        r: {
                            beginAtZero: true,
                            max: 12
                        }
                    },
                    plugins: {
                        legend: {
                            display: false
                        }
                    }
                }
            });
            
            // Gr√°fico de Frequ√™ncia
            const frequenciaMedicamentosCtx = document.getElementById('frequenciaMedicamentosChart').getContext('2d');
            new Chart(frequenciaMedicamentosCtx, {
                type: 'doughnut',
                data: {
                    labels: ['Pembrolizumab', 'Rituximab', 'Bevacizumab', 'Cetuximab', 'Trastuzumab'],
                    datasets: [{
                        data: [10, 10, 6, 3, 3],
                        backgroundColor: [
                            colors.primary,
                            colors.accent,
                            colors.purple,
                            colors.warning,
                            colors.success
                        ],
                        borderWidth: 4,
                        borderColor: '#ffffff'
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    plugins: {
                        legend: {
                            position: 'bottom',
                            labels: {
                                padding: 20,
                                usePointStyle: true
                            }
                        }
                    }
                }
            });
            
            // Gr√°fico de Custos Comparativo
            const custosComparativoCtx = document.getElementById('custosComparativoChart').getContext('2d');
            new Chart(custosComparativoCtx, {
                type: 'bar',
                data: {
                    labels: ['Pembrolizumab', 'Bevacizumab', 'Rituximab', 'Cetuximab', 'Trastuzumab'],
                    datasets: [{
                        label: 'Custo Mensal (R$ mil)',
                        data: [15, 12, 8, 6, 5.5],
                        backgroundColor: [
                            colors.danger,
                            colors.warning,
                            colors.primary,
                            colors.secondary,
                            colors.success
                        ],
                        borderRadius: 8,
                        borderWidth: 2,
                        borderColor: [
                            colors.danger,
                            colors.warning,
                            colors.primary,
                            colors.secondary,
                            colors.success
                        ]
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            ticks: {
                                callback: function(value) {
                                    return 'R$ ' + value + 'k';
                                }
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            display: false
                        }
                    }
                }
            });
            
            // Gr√°fico de Proje√ß√£o de Custos
            const projecaoCustosCtx = document.getElementById('projecaoCustosChart').getContext('2d');
            new Chart(projecaoCustosCtx, {
                type: 'line',
                data: {
                    labels: ['Jan', 'Fev', 'Mar', 'Abr', 'Mai', 'Jun', 'Jul', 'Ago', 'Set', 'Out', 'Nov', 'Dez'],
                    datasets: [
                        {
                            label: 'Pembrolizumab',
                            data: [150, 150, 150, 150, 150, 150, 150, 150, 150, 150, 150, 150],
                            borderColor: colors.danger,
                            backgroundColor: 'rgba(239, 68, 68, 0.1)',
                            borderWidth: 3,
                            fill: true,
                            tension: 0.4
                        },
                        {
                            label: 'Rituximab',
                            data: [80, 80, 80, 80, 80, 80, 80, 80, 80, 80, 80, 80],
                            borderColor: colors.primary,
                            backgroundColor: 'rgba(124, 58, 237, 0.1)',
                            borderWidth: 3,
                            fill: true,
                            tension: 0.4
                        },
                        {
                            label: 'Bevacizumab',
                            data: [72, 72, 72, 72, 72, 72, 72, 72, 72, 72, 72, 72],
                            borderColor: colors.warning,
                            backgroundColor: 'rgba(245, 158, 11, 0.1)',
                            borderWidth: 3,
                            fill: true,
                            tension: 0.4
                        }
                    ]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: {
                        y: {
                            beginAtZero: true,
                            title: {
                                display: true,
                                text: 'Custo Mensal (R$ mil)'
                            }
                        }
                    },
                    plugins: {
                        legend: {
                            position: 'top'
                        }
                    }
                }
            });
        });
    </script>
</body>
</html>